"Cyclosporine" - Books

Result Filters

Results: 1 to 20 of 432 books (2677 items)

<< First< Prev

Page of 22

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

Top results in this book Table of Contents

Select item 42459542.

Calcineurin Inhibitors for Renal Transplant [Internet].

Leas BF, Uhl S, Sawinski DL, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar. (Comparative Effectiveness Reviews, No. 166.)

Top results in this book Table of Contents

Select item 26591823.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 34012944.

Endotext [Internet].

Feingold KR, Ahmed SF, Anawalt B, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 48538165.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 42837766.

Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT).

Williams JG, Alam MF, Alrubaiy L, et al.

Southampton (UK): NIHR Journals Library; 2016 Jun. (Health Technology Assessment, No. 20.44.)

Top results in this book Table of Contents

Select item 50019167.

Clinical Review Report: Cyclosporine (VERKAZIA): (Santen Canada Inc.): Indication: Treatment of severe vernal keratoconjunctivitis in children from four years of age through adolescence [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jan.

Top results in this book Table of Contents

Select item 16686908.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

Top results in this book Table of Contents

Select item 50018269.

Pharmacoeconomic Review Report: Cyclosporine (Verkazia): (Santen Canada Inc.): Indication: Treatment of severe vernal keratoconjunctivitis in children from four years of age through adolescence [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jan.

Top results in this book Table of Contents

Select item 568529610.

The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]. 8th edition.

Sureda A, Corbacioglu S, Greco R, et al., editors.

Cham (CH): Springer; 2024.

Top results in this book Table of Contents

Select item 458577811.

Apremilast (Otezla) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep.

Top results in this book Table of Contents

Select item 558588212.

Abrocitinib (Cibinqo): CADTH Reimbursement Review: Therapeutic area: Atopic dermatitis, moderate to severe [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jan.

Top results in this book Table of Contents

Select item 141528013.

Madame Curie Bioscience Database [Internet].

Austin (TX): Landes Bioscience; 2000-2013.

Top results in this book Table of Contents

Select item 560341214.

Upadacitinib (Rinvoq): CADTH Reimbursement Review: Therapeutic area: Atopic dermatitis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.

Top results in this book Table of Contents

Select item 562190815.

Tralokinumab (Adtralza): CADTH Reimbursement Review: Therapeutic area: Atopic dermatitis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Top results in this book Table of Contents

Select item 538277216.

Skills in Rheumatology [Internet].

Almoallim H, Cheikh M, editors.

Singapore: Springer; 2021.

Top results in this book Table of Contents

Select item 511984017.

Clinical Review Report: Dupilumab (Dupixent): (Sanofi Genzyme, a division of sanofi-aventis Canada Inc.): Indication: Indicated for the treatment of patients aged 12 years and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jun.

Top results in this book Table of Contents

Select item 568902418.

Tralokinumab (Adtralza): Therapeutic area: Atopic dermatitis: CADTH Reimbursement Review [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Sep.

Top results in this book Table of Contents

Select item 556002219.

Dupilumab (Dupixent): CADTH Reimbursement Review: Therapeutic area: Atopic dermatitis, pediatrics [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Dec.

Top results in this book Table of Contents

Select item 282152420.

PDQ Cancer Information Summaries [Internet].

Bethesda (MD): National Cancer Institute (US); 2002-.

Top results in this book Table of Contents

<< First< Prev

Page of 22

Next >Last >>

Supplemental Content

Images search in Bookshelf

Figure 2Subgroups Forest Plot of Four-Times-Daily Cyclosporine 0.1% Versus Placebo Comparison in Primary End Point (FAS)

Diff. = difference; FAS = full analysis set; LS = least squares; VAS: visual analogue scale; VKC = vernal keratoconjunctivitis; vs. = versus.
Source: CADTH Common Drug Review submission: Verkazia (cyclosporine), topical ophthalmic emulsion, 0.1% w/v [CONFIDENTIAL manufacturer’s submission].⁸^,¹⁵

Clinical Evidence.

Clinical Review Report: Cyclosporine (VERKAZIA): (Santen Canada Inc.): Indication: Treatment of severe vernal keratoconjunctivitis in children from four years of age through adolescence [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jan.
Figure 3Subgroups Forest Plot of Twice-Daily Cyclosporine 0.1% Versus Placebo Comparison in Primary End Point (FAS)

Diff. = difference; FAS = full analysis set; LS = least squares; VAS: visual analogue scale; VKC = vernal keratoconjunctivitis; vs. = versus.
Source: CADTH Common Drug Review submission: Verkazia (cyclosporine), topical ophthalmic emulsion, 0.1% w/v [CONFIDENTIAL manufacturer’s submission].⁸

Clinical Evidence.

Clinical Review Report: Cyclosporine (VERKAZIA): (Santen Canada Inc.): Indication: Treatment of severe vernal keratoconjunctivitis in children from four years of age through adolescence [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jan.
Forest Plot F-22Conversion from cyclosporine to mTOR inhibitors: renal function

Forest Plots for Key Questions 3a and 3b.

Leas BF, Uhl S, Sawinski DL, et al. Calcineurin Inhibitors for Renal Transplant [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar.
Forest Plot F-24Conversion from cyclosporine to mTOR inhibitors: graft loss

Forest Plots for Key Questions 3a and 3b.

Leas BF, Uhl S, Sawinski DL, et al. Calcineurin Inhibitors for Renal Transplant [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar.